These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8485045)

  • 41. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.
    Hehlmann R; Berger U; Pfirrmann M; Hochhaus A; Metzgeroth G; Maywald O; Hasford J; Reiter A; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Griesshammer M; Nerl C; Kuse R; Tobler A; Eimermacher H; Tichelli A; Aul C; Wilhelm M; Fischer JT; Perker M; Scheid C; Schenk M; Weiss J; Meier CR; Kremers S; Labedzki L; Schmeiser T; Lohrmann HP; Heimpel H;
    Leukemia; 2003 Aug; 17(8):1529-37. PubMed ID: 12886239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013.
    Silver RT; Peterson BL; Szatrowski TP; Powell BL; Stock W; Carroll AJ; Bloomfield CD; Schiffer CA; Larson RA
    Leuk Lymphoma; 2003 Jan; 44(1):39-48. PubMed ID: 12691141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.
    Li YF; Deng ZK; Xuan HB; Zhu JB; Ding BH; Liu XN; Chen BA
    Chin Med J (Engl); 2009 Jun; 122(12):1413-7. PubMed ID: 19567163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha.
    Mahon FX; Fabères C; Pueyo S; Cony-Makhoul P; Salmi R; Boiron JM; Marit G; Bilhou-Nabera C; Carrère A; Montastruc M; Pigneux A; Bernard P; Reiffers J
    Blood; 1998 Dec; 92(11):4059-65. PubMed ID: 9834210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.
    Hochhaus A; Lin F; Reiter A; Skladny H; van Rhee F; Shepherd PC; Allan NC; Hehlmann R; Goldman JM; Cross NC
    Br J Haematol; 1995 Sep; 91(1):126-31. PubMed ID: 7577619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.
    Talpaz M; Estrov Z; Kantarjian H; Ku S; Foteh A; Kurzrock R
    J Clin Invest; 1994 Oct; 94(4):1383-9. PubMed ID: 7929813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis.
    Kantarjian HM; O'Brien S; Cortes JE; Shan J; Giles FJ; Rios MB; Faderl SH; Wierda WG; Ferrajoli A; Verstovsek S; Keating MJ; Freireich EJ; Talpaz M
    Cancer; 2003 Feb; 97(4):1033-41. PubMed ID: 12569603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of minimal residual disease in patients with chronic myeloid leukaemia on IFN-alpha 2b therapy using conventional cytogenetics and fluorescence in situ hybridization.
    Talwar R; Choudhry VP; Jobanputra V; Kucheria K
    Natl Med J India; 2002; 15(4):195-8. PubMed ID: 12296472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Molecular implication of Ph positive leukemias: treatment with alpha-interferon in Ph positive acute leukemia].
    Ohyashiki JH; Kawakubo K; Ohyashiki K; Toyama K
    Rinsho Byori; 1993 Dec; 41(12):1305-9. PubMed ID: 8295339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-alpha (IFN-alpha) therapy.
    Cox-Froncillo MC; Cantonetti M; Masi M; Lentini R; Giudiceandrea P; Maffei L; Tribalto M; Amadori S; Papa G
    Cancer Genet Cytogenet; 1995 Oct; 84(1):15-8. PubMed ID: 7497436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of interferon alfa-2a to treat hematologic relapse of chronic myelogenous leukemia after bone marrow transplantation.
    Higano CS; Raskind WH; Singer JW
    Acta Haematol; 1993; 89 Suppl 1():8-14. PubMed ID: 8475671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy.
    Eberlé F; Toiron Y; Camerlo J; Lafage M; Sainty D; Arnoulet C; Raineri V; Gabert J; Maraninchi D; Mannoni P
    Leuk Lymphoma; 1995 Jun; 18(1-2):153-7. PubMed ID: 8580818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.
    Cortes J; Kantarjian H; O'Brien S; Robertson LE; Pierce S; Talpaz M
    Am J Med; 1996 Apr; 100(4):452-5. PubMed ID: 8610733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The detection of Philadelphia chromosome negative metaphases in long-term bone marrow cultures of the peripheral blood from patients with chronic myeloid leukemia predicts response to interferon-alpha 2a.
    Gronthos S; To LB; Moore S; Suttle JM; Juttner CA
    Leukemia; 1992 Dec; 6(12):1246-9. PubMed ID: 1453769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BCR-ABL-positive progenitors in chronic myeloid leukaemia patients in complete cytogenetic remission after treatment with interferon-alpha.
    Reiter A; Marley SB; Hochhaus A; Sohal J; Raanani P; Hehlmann R; Gordon MY; Goldman JM; Cross NC
    Br J Haematol; 1998 Sep; 102(5):1271-8. PubMed ID: 9753056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group.
    Ohnishi K; Tomonaga M; Kamada N; Onozawa K; Kuramoto A; Dohy H; Mizoguchi H; Miyawaki S; Tsubaki K; Miura Y; Omine M; Kobayashi T; Naoe T; Ohshima T; Hirashima K; Ohtake S; Takahashi I; Morishima Y; Naito K; Asou N; Tanimoto M; Sakuma A; Ohno R
    Leuk Res; 1998 Sep; 22(9):779-86. PubMed ID: 9716008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response to recombinant interferon alpha in patients with chronic myelogenous leukemia in a single center: results and analysis of predictive factors.
    Montastruc M; Mahon FX; Fabères C; Marit G; Bilhou-Nabera C; Cony-Makhoul P; Puntous M; Pigneux A; Boiron JM; Bernard P
    Leukemia; 1995 Dec; 9(12):1997-2002. PubMed ID: 8609708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
    O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM
    Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.